167 related articles for article (PubMed ID: 34584128)
21. Alteration of Human Papillomavirus Type 16 Genetic and Epigenetic Profiles in Cervical Cancer Patients Is Indicative of Poor Disease Prognosis: A Cohort Analysis.
Dutta S; Singh RK; Mandal RK; Roychoudhury S; Basu P; Panda CK
Int J Gynecol Cancer; 2016 May; 26(4):750-7. PubMed ID: 27051049
[TBL] [Abstract][Full Text] [Related]
22. Human papillomavirus independent status on pathologic response and outcomes in locally advanced cervical cancer managed with chemoradiotherapy followed by surgery.
Turco LC; Pedone Anchora L; Fedele C; Inzani F; Piermattei A; Martini M; Volpe M; Marchetti S; Santangelo R; Bizzarri N; Cosentino F; Vargiu V; De Ninno M; Macchia G; Valentini V; Zannoni G; Scambia G; Ferrandina G
Int J Gynecol Cancer; 2023 Apr; 33(4):489-497. PubMed ID: 36720505
[TBL] [Abstract][Full Text] [Related]
23. Differential clinical characteristics, treatment response and prognosis of locally advanced adenocarcinoma/adenosquamous carcinoma and squamous cell carcinoma of cervix treated with definitive radiotherapy.
Chen JL; Huang CY; Huang YS; Chen RJ; Wang CW; Chen YH; Cheng JC; Cheng AL; Kuo SH
Acta Obstet Gynecol Scand; 2014 Jul; 93(7):661-8. PubMed ID: 24666257
[TBL] [Abstract][Full Text] [Related]
24. Clinical implications of human papillomavirus genotype in cervical adeno-adenosquamous carcinoma.
Lai CH; Chou HH; Chang CJ; Wang CC; Hsueh S; Huang YT; Chen YR; Chang HP; Chang SC; Lin CT; Chao A; Qiu JT; Huang KG; Chen TC; Jao MS; Chen MY; Liou JD; Huang CC; Chang TC; Patsner B
Eur J Cancer; 2013 Feb; 49(3):633-41. PubMed ID: 23031554
[TBL] [Abstract][Full Text] [Related]
25. Completion hysterectomy after chemoradiotherapy for locally advanced adeno-type cervical carcinoma: updated survival outcomes and experience in post radiation surgery.
Yang J; Yang J; Cao D; Shen K; Ma J; Zhang F
J Gynecol Oncol; 2020 Mar; 31(2):e16. PubMed ID: 31912674
[TBL] [Abstract][Full Text] [Related]
26. Tumor hypoxia, p53, and prognosis in cervical cancers.
Haensgen G; Krause U; Becker A; Stadler P; Lautenschlaeger C; Wohlrab W; Rath FW; Molls M; Dunst J
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):865-72. PubMed ID: 11429213
[TBL] [Abstract][Full Text] [Related]
27. Genomic alterations in STK11 can predict clinical outcomes in cervical cancer patients.
Hirose S; Murakami N; Takahashi K; Kuno I; Takayanagi D; Asami Y; Matsuda M; Shimada Y; Yamano S; Sunami K; Yoshida K; Honda T; Nakahara T; Watanabe T; Komatsu M; Hamamoto R; Kato MK; Matsumoto K; Okuma K; Kuroda T; Okamoto A; Itami J; Kohno T; Kato T; Shiraishi K; Yoshida H
Gynecol Oncol; 2020 Jan; 156(1):203-210. PubMed ID: 31757465
[TBL] [Abstract][Full Text] [Related]
28. HPV ctDNA detection of high-risk HPV types during chemoradiotherapy for locally advanced cervical cancer.
Cabel L; Bonneau C; Bernard-Tessier A; Héquet D; Tran-Perennou C; Bataillon G; Rouzier R; Féron JG; Fourchotte V; Le Brun JF; Benoît C; Rodrigues M; Scher N; Minsat M; Legrier ME; Bièche I; Proudhon C; Sastre-Garau X; Bidard FC; Jeannot E
ESMO Open; 2021 Jun; 6(3):100154. PubMed ID: 34022731
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of pre-treatment human papilloma virus DNA status in cervical cancer.
Chong GO; Lee YH; Han HS; Lee HJ; Park JY; Hong DG; Lee YS; Cho YL
Gynecol Oncol; 2018 Jan; 148(1):97-102. PubMed ID: 29153540
[TBL] [Abstract][Full Text] [Related]
30. P16 and HPV Genotype Significance in HPV-Associated Cervical Cancer-A Large Cohort of Two Tertiary Referral Centers.
da Mata S; Ferreira J; Nicolás I; Esteves S; Esteves G; Lérias S; Silva F; Saco A; Cochicho D; Cunha M; Del Pino M; Ordi J; Félix A
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669021
[TBL] [Abstract][Full Text] [Related]
31. Extrafascial hysterectomy after concurrent chemoradiotherapy in locally advanced cervical adenocarcinoma.
Yang J; Shen K; Wang J; Yang J; Cao D
J Gynecol Oncol; 2016 Jul; 27(4):e40. PubMed ID: 27102248
[TBL] [Abstract][Full Text] [Related]
32. HPV genotypes predict survival benefits from concurrent chemotherapy and radiation therapy in advanced squamous cell carcinoma of the cervix.
Wang CC; Lai CH; Huang YT; Chao A; Chou HH; Hong JH
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):e499-506. PubMed ID: 22889667
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the efficacy of prophylactic extended field irradiation in the concomitant chemoradiotherapy treatment of locally advanced cervical cancer, stage IIIB in the 2018 FIGO classification.
Meng Q; Liu X; Wang W; Hou X; Lian X; Sun S; Yan J; Liu Z; Miao Z; Hu K; Zhang F
Radiat Oncol; 2019 Dec; 14(1):228. PubMed ID: 31842919
[TBL] [Abstract][Full Text] [Related]
34. Definitive concurrent chemoradiotherapy in cervical cancer--a University of Malaya Medical Centre experience.
Zamaniah WI; Mastura MY; Phua CE; Adlinda A; Marniza S; Rozita AM
Asian Pac J Cancer Prev; 2014; 15(20):8987-92. PubMed ID: 25374241
[TBL] [Abstract][Full Text] [Related]
35. Outcome of international Federation of gynecology and obstetrics stage IIb cervical cancer from 2003 to 2012: an evaluation of treatments and prognosis: a retrospective study.
Guo L; Liu X; Wang L; Sun H; Huang K; Li X; Tang F; Li S; Yuan X; Wang C
Int J Gynecol Cancer; 2015 Jun; 25(5):910-8. PubMed ID: 25867278
[TBL] [Abstract][Full Text] [Related]
36. Postreatment squamous cell carcinoma antigen as a survival prognostic factor in patients with locally advanced cervical cancer. A Spanish multicenter study. The SEGO Spain-GOG group.
Benito V; Lubrano A; Pérez-Regadera JF; Torné A; Gil-Moreno A; Tejerizo-Garcia Á; Vergés R; Díaz-Feijoo B;
Gynecol Oncol; 2021 Aug; 162(2):407-412. PubMed ID: 34119366
[TBL] [Abstract][Full Text] [Related]
37. Magnetic resonance imaging-based validation of the 2018 FIGO staging system in patients treated with definitive radiotherapy for locally advanced cervix cancer.
Kim J; Cho Y; Kim N; Chung SY; Kim JW; Lee IJ; Kim YB
Gynecol Oncol; 2021 Mar; 160(3):735-741. PubMed ID: 33358037
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors for patients with cervical cancer treated with concurrent chemoradiotherapy: a retrospective analysis in a Japanese cohort.
Endo D; Todo Y; Okamoto K; Minobe S; Kato H; Nishiyama N
J Gynecol Oncol; 2015 Jan; 26(1):12-8. PubMed ID: 25310853
[TBL] [Abstract][Full Text] [Related]
39. Human papilloma virus early proteins E6 (HPV16/18-E6) and the cell cycle marker P16 (INK4a) are useful prognostic markers in uterine cervical carcinomas in Qassim Region--Saudi Arabia.
Omran OM; AlSheeha M
Pathol Oncol Res; 2015 Jan; 21(1):157-66. PubMed ID: 24925218
[TBL] [Abstract][Full Text] [Related]
40. The Prognosis and Risk Stratification Based on Pelvic Lymph Node Characteristics in Patients With Locally Advanced Cervical Squamous Cell Carcinoma Treated With Concurrent Chemoradiotherapy.
Li X; Wei LC; Zhang Y; Zhao LN; Li WW; Ping LJ; Dang YZ; Hu J; Shi M
Int J Gynecol Cancer; 2016 Oct; 26(8):1472-9. PubMed ID: 27400321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]